Worthy, the CYP1B1 inhibitor TMS prevented the stimulatory effects on tumor growth exerted by estrogenic GPER signaling both in vitro and in vivo, in accordance with previous studies that highlighted the ability of this agent to delay tumor progression in xenograft models [13]. Here, GPER1 is linked to neoplasm.